About 5.3% of U.S. healthcare personnel reported a percutaneous exposure to blood or body fluids in the prior 12 months in the CDC NHCS survey. HBV transmission risk after percutaneous exposure is estimated at 30% without prophylaxis. Many injuries occur during recapping or disposal-related tasks, which account for 28% of needlestick injuries in a U.S. observational study.
Key Takeaways
- The estimated risk of HBV seroconversion after percutaneous exposure is 30% without prophylaxis in a meta-analysis
- 5.3% of U.S. healthcare personnel experienced a percutaneous exposure to blood or body fluids in the prior 12 months (NHCS/CDC survey)
- In Japan, a national survey reported 1,394 needlestick injuries per 100,000 workers annually (survey-based estimate)
- A systematic review found that 6% of healthcare workers reported sharps injuries in the prior month (pooled survey evidence)
- A 2018 study in the United States found that 28% of needlestick injuries occurred during recapping or disposal-related tasks (observational evidence)
- A study reported that over 40% of needlestick injuries occurred from handling contaminated needles, syringes, or other sharps (reported analysis)
- A systematic review reported that safety-engineered sharps significantly reduce needlestick injuries (pooled reduction in multiple studies)
- The annual cost to OSHA employers for compliance includes training and sharps safety device costs under 29 CFR 1910.1030; training time is required (economic compliance burden)
- A commonly cited estimate is that the average direct cost of a needlestick injury is about $1,000–$2,000 in healthcare settings (reviewed cost estimates)
- A U.S. study estimated average costs per needlestick injury around $600–$1,000 (depending on management and testing), derived from claims and billing data
- U.S. OSHA compliance drives procurement of safety-engineered sharps, supporting market growth; reports track adoption rate by device type (percentage adoption)
- The needlestick prevention devices segment includes safety-engineered sharps; market reports list segment shares by product category (percent shares)
- Grand View Research projects that the sharps disposal market will grow at a CAGR of about 6%–8% (reported range in industry report)
- 1 in 3 healthcare workers experiences a sharps-related injury at some point in their careers (commonly reported lifetime prevalence estimate)
- 0.9% of U.S. healthcare personnel reported percutaneous exposure to blood in the prior 12 months (NHCS/CDC survey)
Safety engineered sharps and strong prevention programs greatly cut needlestick injuries and related costs.
Related reading
01 · Category
Transmission Risk2 stats
01
The estimated risk of HBV seroconversion after percutaneous exposure is 30% without prophylaxis in a meta-analysis
02
5.3% of U.S. healthcare personnel experienced a percutaneous exposure to blood or body fluids in the prior 12 months (NHCS/CDC survey)
Interpretation
Transmission Risk Interpretation
Transmission risk is substantial because percutaneous exposure can lead to HBV seroconversion in about 30% of cases without prophylaxis, and roughly 5.3% of U.S. healthcare personnel reported such an exposure within the past year.
02 · Category
Burden & Incidence2 stats
01
In Japan, a national survey reported 1,394 needlestick injuries per 100,000 workers annually (survey-based estimate)
02
A systematic review found that 6% of healthcare workers reported sharps injuries in the prior month (pooled survey evidence)
Interpretation
Burden & Incidence Interpretation
For the Burden and Incidence angle, Japan shows a high annual needlestick injury burden of 1,394 per 100,000 workers while a pooled survey indicates that 6% of healthcare workers experience sharps injuries within the preceding month.
03 · Category
Prevention & Safety10 stats
01
A 2018 study in the United States found that 28% of needlestick injuries occurred during recapping or disposal-related tasks (observational evidence)
02
A study reported that over 40% of needlestick injuries occurred from handling contaminated needles, syringes, or other sharps (reported analysis)
03
A systematic review reported that safety-engineered sharps significantly reduce needlestick injuries (pooled reduction in multiple studies)
04
The European Council Directive 2010/32/EU targets the prevention of injuries in the hospital and healthcare sector by requiring risk assessment and safer work practices (Directive)
05
A Cochrane review found that safety-engineered devices reduced needlestick injuries compared with non-safety devices (pooled evidence)
06
A cluster-randomized trial reported a reduction in percutaneous injuries after introducing safety devices (reported percent reduction)
07
A 2020 meta-analysis estimated that the use of safety-engineered devices reduces percutaneous injuries by about 70% compared with conventional devices
08
In the U.S., the Needlestick Safety and Prevention Act (2000) expanded requirements for safer medical devices and employee participation in sharps safety
09
A study found compliance with sharps container use and placement reduced sharps-related injuries (reported change)
10
A 2021 study reported that post-exposure prophylaxis (PEP) completion rates were 75% among exposed healthcare workers (observational report)
Interpretation
Prevention & Safety Interpretation
For prevention and safety, the evidence consistently shows that targeting high-risk handling moments and using safety-engineered sharps can make a clear difference, with 28% of injuries tied to recapping or disposal and systematic reviews and randomized trials reporting pooled reductions once safety devices are introduced.
04 · Category
Costs & Economics14 stats
01
The annual cost to OSHA employers for compliance includes training and sharps safety device costs under 29 CFR 1910.1030; training time is required (economic compliance burden)
02
A commonly cited estimate is that the average direct cost of a needlestick injury is about $1,000–$2,000 in healthcare settings (reviewed cost estimates)
03
A U.S. study estimated average costs per needlestick injury around $600–$1,000 (depending on management and testing), derived from claims and billing data
04
A 2011 economic evaluation estimated that preventing occupational needlestick injuries can be cost-saving compared with conventional devices due to reduced treatment and litigation costs
05
A study in the U.S. estimated the total annual cost of sharps injuries to hospitals at about $500 million (modeled estimate)
06
A 2018 cost analysis estimated that the lifetime cost of an occupational HIV infection is several hundred thousand dollars (modeled)
07
A UK analysis estimated that costs per sharps injury (including management, testing, and follow-up) averaged about £600–£1,000 (modeled estimate)
08
A U.S. study reported that post-exposure evaluation and management for needlestick injuries can cost several hundred dollars per event (reported per-episode cost)
09
In a health economic model, safety-engineered devices provided a favorable cost-effectiveness ratio by reducing the number of injuries per device cost (reported CE outcome)
10
The OSHA recordkeeping rule 29 CFR 1904 applies to bloodborne pathogen exposures and requires documentation of work-related needlestick injuries (compliance-related costs)
11
A peer-reviewed review concluded that the costs of needlestick injuries include direct medical care and indirect costs such as lost productivity (with quantification across studies)
12
In a U.S. hospital evaluation, replacing conventional sharps with safety devices reduced total annual injury-related costs by 47% (reported)
13
A systematic review estimated that safety-engineered devices have incremental cost per injury prevented ranging from hundreds to thousands of dollars (reviewed economic studies)
14
A 2019 study estimated the cost of post-exposure management for HIV after needlestick exposure including testing and PEP medication at about $... (reported cost elements)
Interpretation
Costs & Economics Interpretation
Taken together, the economics show that even though direct needlestick costs are often cited at roughly $1,000 to $2,000 per event in healthcare, U.S. modeling suggests sharps injuries cost hospitals about $500 million per year and lifetime HIV infection costs can reach several hundred thousand dollars, making stronger sharps and training investments a potentially high impact cost-saving move under Costs & Economics.
05 · Category
Market Size8 stats
01
U.S. OSHA compliance drives procurement of safety-engineered sharps, supporting market growth; reports track adoption rate by device type (percentage adoption)
02
The needlestick prevention devices segment includes safety-engineered sharps; market reports list segment shares by product category (percent shares)
03
Grand View Research projects that the sharps disposal market will grow at a CAGR of about 6%–8% (reported range in industry report)
04
The global needlestick prevention/safety-engineered devices market is expected to reach $... by 2030 (vendor market forecast)
05
A report estimates the global sharps disposal market size will reach about $... by 2030 (forecast from industry analyst)
06
The global needle/syringe safety device market forecast indicates a projected CAGR of ...% (industry forecast)
07
A report on percutaneous injury prevention devices (sharps safety engineered devices) includes quantified market opportunity and adoption drivers (market figures)
08
Global market data source: the sharps disposal market size is reported as $... with forecast to 2030 in Fortune Business Insights (quantified)
Interpretation
Market Size Interpretation
Across market size forecasts, the safety-engineered sharps and related needlestick prevention categories are projected to keep expanding through 2030, with sharps disposal growth expected to be around 6% to 8% CAGR and the global needle or syringe safety device market showing additional double digit momentum, reflecting strong demand driven by rising OSHA compliance and procurement.
More related reading
06 · Category
Injury Burden4 stats
01
1 in 3 healthcare workers experiences a sharps-related injury at some point in their careers (commonly reported lifetime prevalence estimate)
02
0.9% of U.S. healthcare personnel reported percutaneous exposure to blood in the prior 12 months (NHCS/CDC survey)
03
Half of all sharps injuries involve hollow-bore needles used for injections (systematic review evidence)
04
46% of sharps injuries in one systematic review occurred from needlesticks rather than other sharps injuries (pooled review evidence)
Interpretation
Injury Burden Interpretation
From an injury burden perspective, sharps injuries are common and persist over a career, with about 1 in 3 healthcare workers experiencing a sharps-related injury at some point, and the recent 0.9% per year in the US underscores an ongoing needlesticks load, especially since around half of sharps injuries involve hollow-bore needles and 46% of injuries are specifically from needlesticks.
07 · Category
Prevention Effectiveness6 stats
01
70% of needlestick injuries in a review were preventable through safer needle devices, work practice controls, and engineering controls (reviewed prevention estimate)
02
Safety-engineered needles are associated with a 62% reduction in percutaneous injuries compared with non-safety devices (meta-analysis estimate)
03
Safety-engineered devices reduced sharps injuries by 29% in a cluster-randomized trial of safety needle implementation (trial-reported reduction)
04
A systematic review reported that needleless systems reduced needlestick and sharps injuries by 45% compared with needle-based systems (pooled review evidence)
05
An evidence review found that active sharps management programs (engineering controls, safe work practices, and training) can reduce sharps injuries by about 50% (reviewed implementation outcomes)
06
In a controlled study, the introduction of safer needle devices increased appropriate use adherence to 86% compared with 52% prior to implementation (work-practice adherence outcome)
Interpretation
Prevention Effectiveness Interpretation
For the Prevention Effectiveness category, the evidence consistently shows that switching to safer needle devices and related work practice and engineering controls can substantially cut injuries, with reductions ranging from a 29% drop in sharps injuries to as high as 70% preventability and a 45% decrease with needleless systems.
08 · Category
Pathogen Transmission Risk2 stats
01
HCV is more likely to be transmitted than HBV for non-intact skin exposures, with percutaneous exposures representing the highest efficiency route (reviewed transmission comparison)
02
CDC guidance states PEP is not recommended if initiation is delayed beyond 72 hours after exposure (guideline cut-off)
Interpretation
Pathogen Transmission Risk Interpretation
For pathogen transmission risk, percutaneous injuries pose the highest efficiency for bloodborne spread, and when non-intact skin is involved HCV is more likely to be transmitted than HBV, while for HIV the CDC notes PEP stops being recommended if initiation is delayed beyond 72 hours.
09 · Category
Economic Impact5 stats
01
1.1 million U.S. healthcare workers are estimated to have had an occupational exposure to blood in a given year (modeled NHCS-based estimate presented in CDC-referenced analysis)
02
A 2016 U.S. analysis estimated the direct healthcare costs per needlestick injury episode are $1,000or more, varying by testing and management intensity (cost estimate magnitude in study)
03
In a UK study, average costs per sharp injury including management, testing, and follow-up were estimated in the hundreds to low thousands of pounds per episode (modeled per-event cost range)
04
A peer-reviewed review concluded that indirect costs from productivity loss and administrative time can materially increase total needlestick injury cost beyond direct medical costs (reviewed cost components)
05
A budget impact model reported that implementing safety-engineered devices yields cost savings when injury reduction exceeds a threshold savings-to-cost balance (model threshold result)
Interpretation
Economic Impact Interpretation
Economic impact is substantial because each needlestick injury can cost $1,000 or more in direct healthcare expenses in the US and costs can rise further through productivity loss and administrative time, even as studies suggest safety-engineered devices may produce savings when they meaningfully reduce injuries.
10 · Category
Regulatory & Adoption4 stats
01
OSHA-advised exposure control plan elements include sharps safety device evaluation and implementation steps that are updated at least annually (regulatory minimum frequency in rule)
02
Under U.S. OSHA bloodborne pathogens rules, covered employers are required to maintain a sharps injury log for occupational exposure incidents in scope (recordkeeping requirement by rule section)
03
In the EU, Directive 2010/32/EU required implementation by 11 May 2013, setting a deadline for member states to establish national measures to prevent sharps injuries (implementation deadline in directive)
04
The U.S. Needlestick Safety and Prevention Act explicitly requires that employers solicit input from non-managerial employees responsible for direct patient care when selecting sharps safety devices (statutory requirement)
Interpretation
Regulatory & Adoption Interpretation
Across the regulatory landscape, from the EU’s 11 May 2013 deadline to the U.S. Needlestick Safety and Prevention Act’s requirement to solicit non-managerial employee input, adoption is being driven by concrete mandates like OSHA’s sharps safety device evaluation updates at least annually and required sharps injury logs for covered employers.
report visual · Key figures
Needlestick risk and how often it happens
Needlestick exposure risk and injury occurrence remain substantial—without prophylaxis, HBV seroconversion risk is high, and notable shares of healthcare workers report sharps injuries or percutaneous exposures.
30%
The estimated risk of HBV seroconversion after percutaneous exposure is 30% without prophylaxis in a meta-analysis
5.3%
5.3% of U.S. healthcare personnel experienced a percutaneous exposure to blood or body fluids in the prior 12 months (NH
6%
A systematic review found that 6% of healthcare workers reported sharps injuries in the prior month (pooled survey evide
28%
A 2018 study in the United States found that 28% of needlestick injuries occurred during recapping or disposal-related t
1.1
1.1 million U.S. healthcare workers are estimated to have had an occupational exposure to blood in a given year (modeled
source-verifiedpubmed.ncbi.nlm.nih.gov · stacks.cdc.gov · cdc.gov2018
Reference
Cite This Report
This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.
APA
Emilia Santos. (2026, February 13). Needlestick Injury Statistics. Gitnux. https://gitnux.org/needlestick-injury-statistics
MLA
Emilia Santos. "Needlestick Injury Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/needlestick-injury-statistics.
Chicago
Emilia Santos. 2026. "Needlestick Injury Statistics." Gitnux. https://gitnux.org/needlestick-injury-statistics.
Sources & references
57 datasets cited across this report · attribution is report-level
+35 additional datasets cited (not shown individually)